Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Fabino Enterprises's Enterprise Value is ₹56.9 Mil.
Fabino Enterprises's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1.7 Mil. Therefore, Fabino Enterprises's EV-to-FCF for today is 32.99.
The historical rank and industry rank for Fabino Enterprises's EV-to-FCF or its related term are showing as below:
BOM:543444'
s EV-to-FCF Range Over the Past 10 Years
Min: -52.57 Med: -8.09 Max: 32.99
Current: 32.99
During the past 8 years, the highest EV-to-FCF of Fabino Enterprises was 32.99. The lowest was -52.57. And the median was -8.09.
BOM:543444's EV-to-FCF is not ranked
in the Drug Manufacturers industry.
Industry Median: 21.61
vs BOM:543444: 32.99
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fabino Enterprises's PE Ratio (TTM) for today is calculated as:
Fabino Enterprises's share price for today is ₹20.31.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fabino Enterprises's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-2.660.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Fabino Enterprises EV-to-FCF Related Terms
Fabino Enterprises EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Fabino Enterprises's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Enterprises's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fabino Enterprises EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fabino Enterprises's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Fabino Enterprises's EV-to-FCF falls into.
Fabino Enterprises's current Enterprise Value is ₹56.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fabino Enterprises's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fabino Enterprises (BOM:543444) has a EV-to-FCF of 32.99 as of Aug. 13, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Fabino Enterprises and its competitors.
Is Fabino Enterprises' EV-to-FCF too high?
Fabino Enterprises' current EV-to-FCF is 32.99. The Drug Manufacturers industry median EV-to-FCF is 21.61. Fabino Enterprises' value of 32.99 is 52.7% above this industry median. Overall, Fabino Enterprises has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Fabino Enterprises' EV-to-FCF compare to ZTS and UTHR?
Fabino Enterprises' EV-to-FCF of 32.99 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-FCF is 21.61. Fabino Enterprises' value of 32.99 is 52.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 21.61, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fabino Enterprises's current EV-to-FCF of 32.99 is 52.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Fabino Enterprises and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 21.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fabino Enterprises's current EV-to-FCF is 32.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabino Enterprises stock overvalued right now?
Fabino Enterprises (BOM:543444) has a current EV-to-FCF of 32.99. The stock's GF Value™ is ₹37.57, compared to a current price of ₹20.31 — trading 45.9% below its estimated fair value. The current EV-to-FCF is 32.99 and 52.7% above the Drug Manufacturers industry median of 21.61. Fabino Enterprises' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Fabino Enterprises (BOM:543444), the current EV-to-FCF is 32.99 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fabino Enterprises (BOM:543444) Overvalued in 2026?
Based on GuruFocus' analysis, Fabino Enterprises stock appears to be undervalued.
The current stock price of ₹20.31 is trading 45.9% below its estimated GF Value™ of ₹37.57.
Key valuation signals for BOM:543444:
EV-to-FCF: 32.99
GF Value™: ₹37.57 vs. price of ₹20.31 (45.9% below fair value)
Industry Position: 52.7% above the Drug Manufacturers median
No single metric tells the full story. See the BOM:543444 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fabino Enterprises Ltd formerly known as Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.
68GF Score
Get the complete analysis for BOM:543444
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543444 has been successfully added to your 
